Precision Medicine in Breast Medicine: A Real Change for Thousands of Women
Gianluca Franceschini, Director of the Integrated Center for Senology and the Breast Surgery Unit of the Gemelli Polyclinic, posted on LinkedIn:
”Precision medicine in Breast Medicine: a real change for thousands of women.
As Director of the Integrated Breast Center of the Gemelli Polyclinic, I see every day how scientific innovation can concretely transform the treatment path of our patients.
- Genomic tests, such as Oncotype DX, are rewriting the therapeutic approach to hormone-responsive breast cancers, which account for more than 70% of diagnoses.
- These tools help us understand who really benefits from chemotherapy and who can be safely treated with hormone therapy alone.
The result?
Thousands of women can avoid unnecessarily heavy treatments without reducing the effectiveness of treatment.
It is a decisive step forward in terms of quality of life, sustainability and personalization of treatment.
We continue to work – together with colleagues in Precision Medicine and National Research Groups – to further expand their use, even in the pre-operative phase, and to define increasingly personalized therapeutic strategies.
Precision medicine is not the future: it is already here. And it’s changing the lives of our patients, one treatment decision at a time.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Università Cattolica del Sacro Cuore
Alessandra Fabi
Gianluca Franceschini ”
Read more here.
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 12:06Reza Shojaei: Why Dried Plasma May Be the Most Important Plasma Innovation in Decades
-
Jun 6, 2026, 08:25Marina Tarunina: Engineered Platelets From Human iPSCs Support Haemostasis Without Thromboembolism
-
Jun 6, 2026, 08:21Razieh Parizad: Systematic Review Evaluates the Future Role of Factor XI Inhibitors in Stroke Prevention
-
Jun 6, 2026, 08:10Vrinda Trivedi: Hematologic Emergencies and Anticoagulation Strategies Spotlighted at CCCES 2026
-
Jun 6, 2026, 08:02Krisstina Gowin: Could the Gut Microbiome Be the Missing Link in Hematology Outcomes?
-
Jun 6, 2026, 07:59Razan Awan: Large Cohort Study Questions Routine Use of Dual Antiplatelet Therapy After TAVI
-
Jun 6, 2026, 07:28Ahmed Dheyaa Al-Obaidi: Retrospective Study Highlights the Role of Transient Elastography in Pediatric Hepatic Fibrosis
-
Jun 6, 2026, 06:55Valeria Galetti: Understanding the Root Causes of Anemia in Madagascar
-
Jun 6, 2026, 06:45Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP